Authors
Latest:
Precision-based DiagnosticsPrecision-based diagnostic approaches can help us improve patient outcomes and reach patient success sooner
Latest:
A First-Class Patient Engagement Service: Do Strategic Partnerships Hold the Key?Delivering a first-class patient engagement approach is complex enough in a large pharma market. For smaller European markets, it can be even more challenging. Ian Riches looks at how pharma companies can put all patients at the center of their engagement plans, no matter which country they live in.
Latest:
CO2 Shortages and the Case for Permanent ULT InfrastructureThe UK‘s imminent CO2 shortage crisis is second time in less than a year that CO2 shortages have threatened critical cold chains. As the demand for COVID-19 vaccines, mRNA-based therapies and precision medicine treatments grows, organizations will have to rethink their ultra-low temperature (ULT) strategies to prevent these shortages from impacting the pharma cold chain, writes Shea Vincent.
Latest:
Future of Personalized Medicine Hinges on Pharma Executives Revolutionizing Business ModelsThe era of big pharma as product-first companies must end, as services become the larger priority.
Latest:
How pharmacies can safeguard Covid-19 vaccine dosesBest practices for pharmacies in storage, monitoring and maintenance of their Covid vaccine shipments
Latest:
Rising sea level: The transportation of pharmaceuticals by sea continues to gain momentum in the quest for greater supply chain resilienceWhen shipping pharmaceuticals internationally, the decision of ocean shipping versus air shipping might seem obvious if the speed of air shipping is the only factor at play when sending sensitive medical supplies and drugs. For the last several years, however, more companies have decided to embrace ocean shipping as a means of delivering their medicines. Industry experts Alan Kennedy and Allan Klinge discuss how, with more cold chain control, a lower carbon footprint and lower costs, ocean-going vessels often have clear advantages over air freight.
Latest:
Improving Cross-Industry Collaboration on Drug Discount ProgramsHow teamwork among safety-net healthcare providers and pharma can make the difference.
Latest:
Advent International, Warburg Pincus Complete $4.25 Billion Acquisition of Baxter’s BioPharma Solutions BusinessThe newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.
Latest:
Study Highlights PBMs’ Role in Drug PricesAn analysis by 3 Axis Advisors has found that there is a large variability in pharmacy reimbursement of prescription drugs depending on PBM contracts with insurers. This creates a system with huge inconsistencies on the prices of both generics and branded products.
Latest:
Fair Market Value vs. Current Market LeverageHow pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services
Latest:
Mark Cuban’s Cost Plus Drugs Partners with Price.comThe two company’s will provide consumers with a platform where they can compare drug prices.
Latest:
Continued Affordability Challenges in the OffingWill result from Medicare reforms, despite increased drug uptake.
Latest:
Why Pharmaceutical Products Need Sustainable PackagingOne packaging aspect—the tape—is often overlooked, but is a valuable component of the shipping process.
Latest:
Raising the stakes for market access supportCase study on closing the gap between new specialty drugs and specialty pharmacies
Latest:
How to Maximize Pharmacy Reimbursement for Every Order and Prevent Costly Write-OffsQuestions pharmacies should ask when choosing the right proof-of-delivery solution
Latest:
Innovation with GenAI: Lessons from Life Sciences and BeyondBy embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.
Latest:
Beyond Payment MethodsThe need for supporting services in copay accumulator and best price areas
Latest:
The Importance of Having the Biopharma Industry Join the Journey to Net-Zero EmissionsHow setting action-based goals and cultivating partnerships will help overcome challenges associated with implementing a sustainable GHG strategy.
Latest:
Driving CAR-Ts for Treatment in Cancer and ImmunologyA deep dive into why this therapy has demonstrated effectiveness in various areas, including for tumors.
Latest:
Innovation with GenAI: Lessons from Life Sciences and BeyondBy embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.
Latest:
Democratizing AI: Bridging the Intelligence Divide in Commercial Life SciencesSmall and emerging biopharma have been historically reserved about artificial intelligence. But, writes Alan Kalton, AI solutions have matured, been proven, and are no longer a risky investment for small to mid-size companies.
Latest:
Realistic Net-Zero Goals for PharmaHow temperature-controlled containers can play key role in the industry's mission for carbon neutrality across the supply chain.
Latest:
M&A in Pharma: Balancing Growth and RiskWhat factors should be considered—and how can both parties benefit long-term?
Latest:
What Will Change in the Pharma Industry Look Like?Exploring how current and future legislation may impact the role of pharmacy benefit managers (PBMs).
Latest:
What Health & Wellness Companies Need to Know About the New Provider/Patient RelationshipHow has the provider-patient relationship transformed over the past two years, and what care are consumers craving?
Latest:
Pharma's Journey with Patient Family Advisory CouncilsIncluding patient and family feedback in our discussions will help shape our understanding of their perception of provided care and services and how we operate as a whole.
Latest:
Creating Value from Compliance DataHow maximizing the intelligence gained from brand engagement compliance activities can help drive pharmaceutical company commercial decisions.
Latest:
Streamlining for Safety: Navigating Changes and Trends in the Pharmaceutical Supply Chain Post-DSCSAWith its aims to protect healthcare consumers against the dangers of counterfeit, contaminated, stolen or otherwise harmful drugs, the DSCSA represents a significant step forward in securing the pharmaceutical supply chain.
